News Agency
Men's Weekly

China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy

  • Written by PR Newswire

 -- pitolisant is the first and only treatment drug approved in mainland China for narcolepsy. 

SHANGHAI, July 4, 2023 /PRNewswire/ -- RareStone Group, a rare disease-focused company aiming to establish the first rare disease ecosystem in China, announced that on June 30, the Chinese National Medical Products Administration (NMPA)...

Read more: China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy

Defense Industry Jobs and Defence Recruitment: Building Careers That Shape National Security

The defence sector is one of the most important contributors to national security, innovation, and economic growth. Across Australia and worldwide, defense industry jobs offer opportunities for individuals to work in fields that combine technology, strategy, and service to the nation... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion